The influence of compound aITEL1296 on telomerase activity and growth of cancer cells

Telomerase is a ribonucleoprotein complex, which synthesizes telomeric repeats and which has been identified as a promising target for anticancer therapy. Here we have investigated the effect of a new compound aITEL1296 on telomerase activity. aITEL1296 effectively inhibited telomerase activity; its inhibitory activity was a bit higher (IC 50 = 0.19 ± 0.02 ng/mL) than that of BIBR1532, one of the most potent telomerase inhibitors known to date. In addition to telomerase inhibition aITEL1296 activated apoptotic mechanisms and effectively suppressed proliferation of tumor cell lines (GI 50 = 5.0 ± 0.2 ng/mL for most sensitive cell line LnCap) but not normal fibroblast cell line. © Pleiades Publishing, Ltd., 2012.

Authors
Kovalenko N.A.1 , Zhdanov D.D. 2, 3 , Bibikova M.V.4 , Gotovtseva V.Y.4
Number of issue
1
Language
English
Pages
48-54
Status
Published
Volume
6
Year
2012
Organizations
  • 1 Research Center, Sechenov First Moscow State Medical University, Moscow, Russian Federation
  • 2 Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, ul. Pogodinskaya 10, Moscow, 119121, Russian Federation
  • 3 Russian Peoples' Friendship University, Ecological Faculty, Moscow, Russian Federation
  • 4 National Research Center of Antibiotics, Moscow, Russian Federation
Keywords
aITEL1296; apoptosis; cancer cells; inhibitor; telomerase; telomere
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/2350/
Share

Other records